{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:39:50Z","timestamp":1792708790182,"version":"4.5.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Immunotherapy has transformed the therapeutic landscape of advanced cervical cancer, yet clinical benefit remains limited by a highly heterogeneous and immunosuppressive tumor microenvironment. Traditional paradigms, including binary M1\/M2 macrophage polarization and models that interpret T-cell dysfunction solely through checkpoint expression, are insufficient to capture the localized intercellular dynamics that drive immune evasion. Recent advances in single-cell and spatial multi-omics have fundamentally reshaped our understanding of this landscape. In this review, we synthesize emerging high-dimensional atlases to reframe macrophage\u2013T-cell crosstalk from simple ligand\u2013receptor interactions into a spatially organized ecological model. We highlight the paradigm shift toward highly resolved myeloid programs, particularly SPP1\n                    <jats:sup>+<\/jats:sup>\n                    and C1QC\n                    <jats:sup>+<\/jats:sup>\n                    macrophage states, and discuss how these programs interact with stromal barriers, regulatory T cells, and metabolic checkpoints to restrict, exclude, or functionally constrain effector T cells within suppressive niches. Crucially, we position persistent high-risk human papillomavirus infection not merely as an initiating carcinogenic trigger, but as an upstream and continuous programmer that rewires innate immune sensing, including context-dependent cGAS\u2013STING-related circuits, to stabilize local immune tolerance throughout disease progression. Finally, we propose translational strategies for distilling complex multi-omic atlases into pathology-compatible prognostic and predictive biomarker signatures. Ultimately, by deciphering these spatially organized networks, this review aims to provide actionable translational insights for targeting macrophage vulnerabilities, guiding biomarker-driven combinatorial immunotherapies, and overcoming immune resistance in cervical cancer.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1896004","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:10Z","timestamp":1784095870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatially organized macrophage\u2013T-cell crosstalk in cervical cancer: insights from single-cell and spatial omics"],"prefix":"10.3389","volume":"17","author":[{"given":"Li","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Oncology, Guiyang Public Health Clinical Center","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Cancer Hospital","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Fifth People\u2019s Hospital","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guiyang Public Health Clinical Center","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Cancer Hospital","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Fifth People\u2019s Hospital","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guiyang Public Health Clinical Center","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Cancer Hospital","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Fifth People\u2019s Hospital","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Guiyang Public Health Clinical Center","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Cancer Hospital","place":["Guiyang, China"]},{"name":"Department of Oncology, Guiyang Fifth People\u2019s Hospital","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00977-w","article-title":"Treatment advances across the cervical cancer spectrum","volume":"22","author":"Francoeur","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01808-7","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa2313811","article-title":"Tisotumab vedotin as second- or third-line therapy for recurrent cervical cancer","volume":"391","author":"Vergote","year":"2024","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02135-4","article-title":"Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China","volume":"404","author":"Wu","year":"2024","journal-title":"Lancet"},{"key":"B7","unstructured":"FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer"},{"key":"B8","unstructured":"FDA Approves Tisotumab Vedotin-Tftv for Recurrent or Metastatic Cervical Cancer"},{"key":"B9","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer. Version 2.2026"},{"key":"B10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12943-026-02600-1","article-title":"Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy","volume":"25","author":"Wang","year":"2026","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1645019","article-title":"HPV infection and the immune microenvironment in cervical cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41418-023-01242-w","article-title":"Activating STING\/TBK1 suppresses tumor growth via degrading HPV16\/18 E7 oncoproteins in cervical cancer","volume":"31","author":"Huang","year":"2024","journal-title":"Cell Death Differ"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1450875","article-title":"Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development","volume":"15","author":"Luo","year":"2024","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1709613","article-title":"The role of cGAS-STING signaling in HPV infection and HPV-related cancers","volume":"16","author":"Zhu","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2023.04.007","article-title":"Contribution of HLA-G and FOXP3 genes and proteins in the severity of cervical intraepithelial neoplasia during HPV infection","volume":"84","author":"da Silva","year":"2023","journal-title":"Hum Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01349","article-title":"The role of HLA-G in human papillomavirus infections and cervical carcinogenesis","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","article-title":"Human papillomaviruses: diversity, infection and host interactions","volume":"20","author":"McBride","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0150-2","article-title":"RNA sequencing: the teenage years","volume":"20","author":"Stark","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","article-title":"Spatial omics and multiplexed imaging to explore cancer biology","volume":"18","author":"Lewis","year":"2021","journal-title":"Nat Methods"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-022-01409-2","article-title":"Museum of spatial transcriptomics","volume":"19","author":"Moses","year":"2022","journal-title":"Nat Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1038\/s41467-025-63414-1","article-title":"Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples","volume":"16","author":"Ozirmak Lermi","year":"2025","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq4964","article-title":"The dawn of spatial omics","volume":"381","author":"Bressan","year":"2023","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the interface of the co-evolving cancer ecosystem","volume":"186","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Binnewies","year":"2021","journal-title":"Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41698-024-00660-4","article-title":"Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census","volume":"8","author":"Wei","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022110757","article-title":"Single-cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment","volume":"42","author":"Cao","year":"2023","journal-title":"EMBO J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12885-025-13901-x","article-title":"Single-cell transcriptomic analysis reveals CD8+ T cell heterogeneity and identifies a prognostic signature in cervical cancer","volume":"25","author":"Zhou","year":"2025","journal-title":"BMC Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101550","article-title":"Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence","volume":"5","author":"Dai","year":"2024","journal-title":"Cell Rep Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000528RR","article-title":"The role of Tim-3\/Galectin-9 pathway in T-cell function and prognosis of patients with human papillomavirus-associated cervical carcinoma","volume":"35","author":"Chen","year":"2021","journal-title":"FASEB J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897366","article-title":"Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203040","article-title":"Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma","volume":"9","author":"Ou","year":"2022","journal-title":"Adv Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41698-025-00948-z","article-title":"Deciphering the cellular and molecular landscape of cervical cancer progression through single-cell and spatial transcriptomics","volume":"9","author":"Xia","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s42003-025-09310-2","article-title":"Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma","volume":"9","author":"Wu","year":"2026","journal-title":"Commun Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1612623","article-title":"Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct HPV-associated immune microenvironment features and prognostic signatures in cervical cancer","volume":"16","author":"Su","year":"2025","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01570-0","article-title":"Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance","volume":"55","author":"Fan","year":"2023","journal-title":"Nat Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41698-024-00637-3","article-title":"Cellular heterogeneity and key subsets of tissue-resident memory T cells in cervical cancer","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12943-025-02471-y","article-title":"Integrated multi-omics identifies a CD54+ iCAF-ITGAL+ macrophage niche driving immunosuppression via CXCL8-PD-L1 axis in cervical cancer","volume":"24","author":"Chen","year":"2025","journal-title":"Mol Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.03.017","article-title":"Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in cervical cancer","volume":"24","author":"Li","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s42003-022-04142-w","article-title":"Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer","volume":"5","author":"Li","year":"2022","journal-title":"Commun Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1219","article-title":"Spatiotemporally deciphering the mechanism of persistent HPV-induced Malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: integrating single-cell RNA sequencing and spatial transcriptome","volume":"13","author":"Guo","year":"2023","journal-title":"Clin Transl Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41419-024-06522-y","article-title":"Single-cell RNA sequencing of cervical exfoliated cells reveals potential biomarkers and cellular pathogenesis in cervical carcinogenesis","volume":"15","author":"Sheng","year":"2024","journal-title":"Cell Death Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100197","article-title":"Multiplex immunohistochemistry and immunofluorescence: a practical update for pathologists","volume":"36","author":"Harms","year":"2023","journal-title":"Mod Pathol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694801","article-title":"Multi-omics analysis showed the clinical value of gene signatures of C1QC+ and SPP1+ TAMs in cervical cancer","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.861392","article-title":"Development and validation of an immune-related prognostic signature in cervical cancer","volume":"12","author":"Su","year":"2022","journal-title":"Front Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41419-019-1748-1","article-title":"Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12964-023-01450-4","article-title":"Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRP\u03b1 axis","volume":"22","author":"Chen","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B55","doi-asserted-by":"publisher","first-page":"116119","DOI":"10.1016\/j.intimp.2025.116119","article-title":"SPP1 enhances radiotherapy resistance through CCL2-mediated M2-like polarization of macrophages in cervical cancer","volume":"172","author":"Jia","year":"2026","journal-title":"International Immunopharmacology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI123360","article-title":"An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion","volume":"128","author":"Klement","year":"2018","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41598-024-81726-y","article-title":"CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12977","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03838-6","article-title":"Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia","volume":"148","author":"Vattai","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02729","article-title":"TCR repertoire as a novel indicator for immune monitoring and prognosis assessment of patients with cervical cancer","volume":"9","author":"Cui","year":"2018","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12885-026-15636-9","article-title":"Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer","volume":"26","author":"Lin","year":"2026","journal-title":"BMC Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04638-w","article-title":"Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia","volume":"149","author":"Vattai","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41419-024-07128-0","article-title":"YTHDF1 boosts lactate accumulation to potentiate cervical cancer cell immune escape","volume":"15","author":"Xiong","year":"2024","journal-title":"Cell Death Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3291","article-title":"DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway","volume":"350","author":"Lau","year":"2015","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000155","article-title":"The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry and immunofluorescence staining and validation","volume":"8","author":"Taube","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1659094","article-title":"Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors","volume":"8","author":"Yang","year":"2019","journal-title":"Oncoimmunology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer \u2013 Update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int J Gynecol Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1896004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:12Z","timestamp":1784095872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1896004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2026.1896004"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1896004","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1896004"}}